60 likes | 62 Views
This preclinical CRO market report is an exhaustive research on companies active in Medical tourism sector, its applications, products, end-users, trends and predictions on how the market will grow in coming years.
E N D
Preclinical CRO market trends research and projections for 2021- 2027 • A research study conducted by Global Market Insights, Inc., suggests that preclinical CRO market is likely to exceed the $7.8 billion mark by 2027, in terms of revenue. Rise in number of drug development activities and growing R&D expenditure in the healthcare sector is expected to drive the preclinical CRO market growth over the forthcoming years. • Rise in number of drug development activities and growing R&D expenditure in the healthcare sector is expected to drive the preclinical CRO market growth over the forthcoming years. The biopharmaceutical and pharmaceutical industry is spending heavily on clinical R&D. • High expenditure associated with such activities have encouraged companies to opt for outsourced preclinical services. The need for deduction in cost and improved productivity builds in further interest in choosing outsourcing or contract research organizations, instigating preclinical CRO market development. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Market Segmentation:- • As per service type, the preclinical CRO industry is classified into DMPK and bioanalysis studies, toxicology testing, and others. The toxicology testing service segment accounted for USD 1.7 billion of the total market revenue. Toxicity studies include testing of toxicity outline of a drug by sensing its effect on functionality or on organ structure. • The preclinical CRO segment is bifurcated into government & academic institutes, medical device companies, biopharmaceutical companies, and others based on end-use. The government and academic institutes will show lucrative growth of 5.6% between 2021 to 2027 owing to the growing number of outsourcing research activities to academic institutes. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Request for a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2860 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Regional Analysis • The Preclinical CRO market of Asia Pacific is expected to grow at a significant pace of 8.6% during the forecast timeframe. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiac diseases is the reason for high growth rate in the region. Ongoing preclinical trials in oncology and the increased number of investigational compounds will pave the way for the growth of preclinical CRO business size in the coming years. • Competitive Analysis • Some of the major companies functioning in the preclinical CRO market include Envigo, Laboratory Corporation of America Holdings, Charles River Laboratories, and Pharmaceutical Product Development among others. Industry players are taking part in strategic initiatives like new/innovative product launches, mergers, acquisitions, and business expansion. Request for Customization @ https://www.gminsights.com/roc/2860 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Latest Research Report On preclinical CRO market @ https://www.gminsights.com/industry-analysis/preclinical-cro-market Request for sample of this research report@ https://www.gminsights.com/request-sample/detail/2860 Request for customization: https://www.gminsights.com/roc/2860 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com